ACTRN12613000588796已完成1 期
A single dose, randomized, blinded, bioequivalence study of desvenlafaxine extended release tablets in a 2 way crossover comparison against the innovator desvenlafaxine extended release tablet conducted under fed conditions in healthy male and female volunteers
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 55 Years（—）
- 性别
- All
入选标准
- •Healthy males and females
- •Aged between 18 and 55
- •Non-smoker
- •BMI between 19 and 30
- •Normal, healthy individuals as determined by medical history, physical examination, ECG, bood pressure and laboratory tests
- •Able to provide written informed consent
排除标准
- •Any history of recent recurrent attacks of bronchitis, asthma, migraine headaches
- •Concomitant drug therapy of any kind (excluding prescribed hormonal contraceptives
- •History of depression, anxiety, obsessive-compulsive disorder, or post-traumatic stress syndrome
- •Pregnant or breast-feeding
- •Sensitivity to desvenlafaxine, any antidepressant agens, excipients of desvenlafaxine
- •History of any conditions that might interfere with the absorption, distribution, metabolism or excretion of the drug
- •Smoker (anyone who has smoked in the last 6 months)
- •History of alcohol or drug abuse or dependency
- •Participation in a drug study within 60 days of the start of the study or donated blood in the 60 days preceding the study.
- •Volunteers for whom the Clinical Investigator believes, for any reason, that participation would not be an acceptable risk.
研究者
相似试验
已完成
1 期
Comparative assessment of the absorption of a generic formulation of ibuprofen sustained release tablet against the innovator ibuprofen sustained release tablet conducted under fasting conditions in healthy male and female volunteersBioequivalence study conducted in healthy volunteers comparing two formulations of Ibuprofen with no health condition or problem studied. Although this study is being conducted in healthy volunteers who are not being treated for the condition to which the medicine is used, ibuprofen belongs to a class of medicines called an analgesic and anti-inflammatory. It is used for the treatment of rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and other non-rheumatoid arthropathiesBioequivalence study conducted in healthy volunteers comparing two formulations of Ibuprofen with no health condition or problem studied.Although this study is being conducted in healthy volunteers who are not being treated for the condition to which the medicine is used, ibuprofen belongs to a class of medicines called an analgesic and anti-inflammatory. It is used for the treatment of rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and other non-rheumatoid arthropathiesOther - Research that is not of generic health relevance and not applicable to specific health categories listed aboveACTRN12614001097639Zenith Technology Corp Ltd24
已完成
1 期
Comparative assessment of the absorption of a generic formulation of dofetilide capsule against the innovator dofetilide capsule conducted under fasting condition in healthy male and female volunteers.Atrial fibrillationACTRN12617000776303Zenith Technology Corporation Limited21
已完成
1 期
Comparative assessment of the absorption of a generic formulation of mesalazine tablet against the innovator mesalazine tablet conducted under fed conditions in healthy male and female volunteersACTRN12618000098235Zenith Technology Corp Ltd36
已完成
1 期
Comparative assessment of the absorption of a generic formulation of aspirin/dipyridamole extended release capsule against the innovator aspirin/dipyridamole extended release capsule conducted under fed conditions in healthy male and female volunteersACTRN12614000275662Zenith Technology Corporation Limited40
已完成
1 期
Comparative assessment of the absorption of a generic formulation of clonidine tablet against the innovator clonidine tablet conducted under fasting conditions in healthy male and female volunteersACTRN12615000280505Zenith Technology Corp Ltd24